The risk of asthma from severe paramyxoviral infection in both human and experimental models is well documented ( 1 -3 ) . This virally imparted risk presents an interesting paradox; although the primary antiviral response is dominated by production of IFN ␣ / ␤ and IL-12, which are hallmarks of a Th1 response, rhinorrhea and mucous cell metaplasia also develop. These conditions are driven by IL-13, which is a hallmark Th2 cytokine ( 4, 5 ) . The production of antiviral IgE, along with neutralizing IgG antibodies, provides a further link between these disparate responses ( 6 -10 ) . In fact, IgE serum concentrations have been correlated with subsequent wheezing in infants with respiratory viral infection and with the risk of otitis media with eff usion in children ( 10, 11 ) . How a Th1-biased response generates a Th2 phenotype is not known, although we now show that the high-affi nity receptor for IgE on DCs bridges the antiviral Th1 response to the atopic/proasthmatic Th2 response.
The role of the high-affi nity receptor for IgE (Fc RI) on human conventional DCs (cDCs) has been assumed to be antigen focusing, with expression being tightly regulated by serum IgE levels, much like it is on basophils ( 12, 13 ) . Fc RI has not been reported on mouse DCs, and little is known of what role it might play during an antiviral response. Indeed, the role of the cDCs in an antiviral immune response is not fully understood. Initial lung cDC migration to draining lymph nodes, and subsequent antigen presentation, has been examined ( 14 -16 ) . However, the role of those cDCs that remain in or are attracted to the lung parenchyma during a primary response has not been evaluated. Although, in the case of secondary viral infections or challenge responses to OVA, the evidence suggests that these cells are involved in recruitment of memory eff ector T cells ( 17, 18 ) . We have developed a mouse model of viral of the high-affi nity receptor for IgE (Fc RI ␣ ), and this expression remained detectable for 2 -3 wk after SeV inoculation ( Fig. 2, A and B ). This response was specifi c to lung cDCs because there was no detectable expression of Fc RI ␣ on cDCs isolated from draining lymph nodes or spleen during SeV infection (unpublished data). CD23, the low-affi nity receptor for IgE, was not induced during the infection ( Fig. 2 B ) . Using intranasal administration of the intravital dye CFSE, which labeled lung cells present at the time of its administration but not cells that subsequently migrated into the lung, we were able to show that Fc RI ␣ -expressing cDCs were present in the lung at the time of the initial viral inoculation and had not migrated into the lung after the onset of infection ( Fig. 2,  C and D ) . The level of expression of Fc RI ␣ on lung cDCs at PI day 7 was similar to levels seen on c-kit ϩ lung mast cells ( Fig. 2, A and E ) . Increased expression of Fc RI after viral infection was relatively selective for cDCs and mast cells because we did not detect expression of Fc RI ␣ on lung CD4 ϩ or CD8 ϩ T cells, B220 ϩ B cells, Mac-3 ϩ macrophages, or Gr-1 ϩ neutrophils (unpublished data). Expression of Fc RI ␣ was detected on 20 -40% of lung pDCs at PI day 3 (unpublished data), bronchiolitis that reproduces disease traits associated with asthma ( 2 ) . In this model, Fc RI was expressed on lung cDCs only during the antiviral response, and these cells were critical for the development of postviral mucous cell metaplasia. Indeed, mice defi cient in Fc RI ( FceRIa -/ -) failed to recruit IL-13 -producing CD4 ϩ T cells to their lungs after viral infection. Cross-linking the ␣ -chain of Fc RI (Fc RI ␣ ) on lung cDCs produced a CD4 ϩ T cell chemoattractant, CCL28, and blockade of this chemokine prevented development of postviral mucous cell metaplasia. Thus, these studies provide a novel insight into how the antiviral response leads to a potent Th2 response through Fc RI ␣ on lung cDCs.
RESULTS

FceRIa -/ -mice fail to develop airway mucous cell metaplasia
We infected FceRIa -/ -mice or WT littermates with the mouse paramyxovirus Sendai virus (SeV). Each strain exhibited similar morbidity (as monitored by weight loss), development of an adaptive immune response (as indicated by the development of SeV-specific CD8 ϩ T cells), and clearance of virus from the lung (based on SeV copy number) during the acute phase of viral infection (Fig. S1 , available at http://www.jem.org/cgi/content/full/jem.20070360/DC1). Previous work in this model has shown that replicating virus is fully cleared by postinoculation (PI) day 12, with the subsequent development of long-lasting mucous cell metaplasia evident by PI day 21 ( 2 ) . Despite a similar acute response to viral infection, we found a marked decrease in the number of Muc5ac-expressing mucous (goblet) cells in the airways of FceRIa -/ -mice compared with WT mice at PI day 21 ( Fig. 1 ) . We have previously shown that Muc5ac induction by PI day 21 depends on production of IL-13 ( 5 ) . Therefore, these fi ndings suggested a link between Fc RI ␣ expression and IL-13 production in the airway response to viral infection.
Paramyxoviral infection induces high-level expression of Fc RI ␣ on resident lung DCs
We next identifi ed which cell type in the lung might express Fc RI ␣ in the setting of viral infection. In rodents, the highaffi nity IgE receptor has been identifi ed only on mast cells, basophils, and possibly eosinophils ( 19 ) . However, in humans, this receptor is also found on skin and peripheral blood cDCs, as well as plasmacytoid DCs (pDCs), albeit as a trimeric form (Fc RI ␣ ␥ ␥ ) that lacks the Fc RI ␤ chain ( 13, 20, 21 ) . Therefore, we questioned whether this form of the receptor might also be found on lung parenchymal cDCs after viral infection. Using forward/side scatter characteristics and a high level of CD11c expression to identify lung cDCs, we have observed that SeV infection leads to a rapid and sustained decrease in the number of lung cDCs, but the cDC population remaining in the lung becomes more mature and diff erentiated ( 22 ) . Therefore, we examined this population of resident cDCs in more detail.
Before infection, lung cDCs failed to express Fc RI; however, by PI day 3, this population began to express the ␣ chain Fc RI proteins, real-time PCR assays showed that lung cDCs expressed Fc RI ␣ , but not Fc RI ␤ mRNA after viral infection, whereas MC9 mast cells contained high levels of both Fc RI ␣ and Fc RI ␤ mRNA (Fig. S2 C) . Thus, mouse lung cDCs express the trimeric (Fc RI ␣ ␥ ␥ ) form of the Fc RI receptor. This is the same form of Fc RI that is expressed by human DCs, but expression on mouse cDCs requires induction by a productive viral infection. This requirement may explain the failure to detect Fc RI expression on mouse DCs in previous works.
Type I IFN receptor, but not IgE, regulates DC expression of Fc RI ␣ Next, we explored what component of the antiviral response is responsible for induction of Fc RI ␣ expression on lung cDCs during a paramyxoviral infection. Serum IgE level tightly regulates expression of the high-affi nity IgE receptor in humans, so we reasoned that total IgE and, more likely, SeVspecifi c IgE might drive Fc RI receptor expression after viral infection in mice. However, we found that serum total IgE and SeV-specifi c IgE do not increase until PI day 7 ( Fig. 3 A ) . This time course lags behind the onset of expression of Fc RI ␣ which is consistent with reports of Fc RI ␣ ␥ ␥ on human pDCs ( 21 ) . This pDC population was distinct from the lung cDC population because Fc RI ␣ -expressing lung cDCs did not express the pDC/B cell marker B220 (Fig. S2 A, available at http://www.jem.org/cgi/content/full/jem.20070360/DC1). Expression of Fc RI did not infl uence cDC maturation or diff erentiation during viral infection. We found no diff erence in the levels of expression of MHC class II, CD11b, CD80, or CD86 between lung cDCs from FceRIa -/ -versus WT mice (Fig. S2, A and B) . Similarly, we found no infl uence of Fc RI on the expression of CD23.
Based on work with isolated cells, mice have been reported to be obligate expressers of the tetrameric form (Fc RI ␣ ␤ ␥ ␥ ) of Fc RI ( 23 ) . To determine if mouse lung cDCs were, indeed, expressing the tetrameric and not trimeric form of the receptor, we analyzed mouse lung cDCs for expression of each Fc RI component chain. Immunoprecipitation of Fc RI with an anti-Fc RI ␣ antibody, and subsequent Western blot with anti-Fc RI ␥ or -Fc RI ␤ antibodies, showed that lung cDCs isolated after SeV infection expressed Fc RI ␥ , but not Fc RI ␤ ( Fig. 2 F ) . In contrast, MC9 mast cells expressed both Fc RI ␥ and Fc RI ␤ . In concert with these fi ndings for Therefore, IgE levels do not appear to regulate the appearance of Fc RI ␣ on lung cDCs after viral infection in mice.
Given that initial expression of Fc RI ␣ developed at the same time as IFN-dependent responses in this viral model, we examined whether IFN signaling was necessary for Fc RI expression. Indeed, we found that type I IFN receptor (IFNAR) -defi cient ( IFNAR Ϫ / Ϫ ) mice no longer exhibited an increase in Fc RI ␣ expression on lung cDCs during viral infection ( Fig. 3 , C -E ). In contrast, mice that were defi cient for CD1d , CD4 , CD8 , perforin , or MyD88 gene expression showed no defect in Fc RI ␣ expression after viral infection (unpublished data). Thus, although IFNAR is critical for expression of Fc RI ␣ on lung cDCs after viral infection, there is no substantial role for NKT cells, CD4 ϩ T cells, or CD8 ϩ T cells, or for the innate antiviral perforin-or MyD88-dependent Tolllike receptor pathways in this process.
We next examined the mechanism for IFN-dependent expression of Fc RI on DCs. We recognized that direct IFN treatment of human lung pDCs failed to increase Fc RI ␣ expression ( 21 ) . This fi nding suggested that IFN-dependent increases in Fc RI expression on lung DCs may involve other cell types besides DCs. Accordingly, we next determined whether IFNAR expression on cDCs was necessary for Fc RI expression after viral infection. For these experiments, we purifi ed lung cDCs from IFNAR Ϫ / Ϫ and WT control mice. We verifi ed that the cells we purifi ed exhibited typical DC morphology ( Fig. 4 ) . Purifi ed lung cDCs were loaded with CFSE (to discriminate from endogenous cDCs) and transferred into WT or IFNAR Ϫ / Ϫ recipients. We found that either IFNAR Ϫ / Ϫ or WT cDC transfer into WT mice allowed for expression of Fc RI ␣ on cDCs ( Lung cDCs from virus-infected mice drive IL-13 production from CD4 ؉ T cells Because IL-13 is thought to drive postviral mucous cell metaplasia, and Th2 cells are thought to be a likely source of IL-13, we reasoned that generation of Th2 cells might be altered as a result of Fc RI ␣ engagement on cDCs ( 5 ). CD8 Ϫ cDCs, like those found in the lung, have been shown to drive T cell development toward a Th2 phenotype in vitro ( 24 ) . Therefore, to determine if induction of IL-13 -producing CD4 ϩ T cells depended on engagement of Fc RI ␣ , we examined IL-13 production in an in vitro cell culture system that contains CD4 ϩ T cells and cDCs. OVA-specifi c CD4 ϩ T cells (OT-II cells) were cultured with lung cDCs isolated from WT or FceRIa Ϫ / Ϫ mice with or without SeV infection. We isolated cDCs at PI day 7 and verifi ed that these cDCs had not yet bound IgE at this time point (unpublished data). We found that OT-II CD4 ϩ T cells produced IL-13 when cultured with antigen and cDCs, regardless of whether cDCs were on lung cDCs, suggesting that the level of IgE is not driving the expression of Fc RI receptor under these conditions. In fact, we found that IgE-defi cient ( IgE Ϫ / Ϫ ) mice continued to develop the same increase in Fc RI ␣ expression on lung cDCs as their WT littermates after viral inoculation ( Fig. 3 B ) . To establish that CCL28 expression was inducible in cDCs with a more physiological stimulus of Fc RI activation, we loaded lung cDCs from PI day 7 with IgE against OVA. In this setting, we found that addition of OVA (by cross-linking anti-OVA IgE bound to Fc RI ␣ on the cDC) caused a marked increase in CCL28 mRNA ( Fig. 5 C ) . Similar results were obtained when using the anti-Fc RI ␣ antibody to directly cross-link the receptor (unpublished data). To determine whether Fc RI activation also caused CCL28 expression in vivo, we returned to experiments with the mouse model of virus-induced lung disease. Again, we found that lung levels of CCL28 mRNA were increased after SeV infection in WT mice, and that this eff ect was lost in FceRIa Ϫ / Ϫ mice ( Fig. 5 D ) . If CCL28 was being released with engagement of Fc RI, then we would expect diff erences in the frequency of CD4 ϩ T cells in the lungs of FceRIa Ϫ / Ϫ and WT mice after viral infection. Indeed, we found that CD4 ϩ T cells were signifi cantly decreased in the lungs of FceRIa Ϫ / Ϫ mice compared with WT mice at PI day 21 ( Fig. 5 E ) .
Because we have previously shown that mucous cell metaplasia after viral infection is dependent on IL-13 production, we next examined the amount of IL-13 and GATA-3 (a Th2-specifi c transcription factor) message in lung CD4 ϩ T cells of WT and FceRIa Ϫ / Ϫ mice after SeV infection ( 5 ). We found a signifi cant decrease in the levels of IL-13 and GATA-3 mRNA in CD4 ϩ T cells from the lungs of FceRIa Ϫ / Ϫ compared with WT mice ( Fig. 5, F and G ) . These fi ndings further supported the proposal that inhibition of mucous cell metaplasia in FceRIa Ϫ / Ϫ mice was based on decreased accumulation of IL-13 -producing CD4 ϩ Th2 cells caused by a lack of production of CCL28 by the resident Fc RI ␣ ϩ lung cDCs. We also examined IL-13 and GATA-3 mRNA levels in the CD4 ϩ T cells that had or had not migrated in response to CCL28 in vitro. We found that there was much greater expression of both IL-13 and GATA-3 mRNA in T cells that isolated from WT or FceRIa Ϫ / Ϫ mice or from infected or uninfected mice ( Fig. 5 A ) . Furthermore, cross-linking Fc RI ␣ had no eff ect on T cell production of IL-13 or proliferation ( Fig. 5 A and not depicted) . Thus, we conclude that lung cDCs are capable of driving the development of IL-13 -producing CD4 + Th2 cells, but this process does not require cDC expression or activation of Fc RI ␣ .
Cross-linking Fc RI ␣ on lung DCs produces the T cell chemoattractant CCL28
Because we did not detect a requirement for cross-linking Fc RI ␣ in the development of the T cell cytokine response, we next assessed whether Fc RI might be involved in the induction of T cell chemoattractants. Lung cDCs were purifi ed from WT mice by immunomagnetic selection at PI day 5. The purifi ed cells were then cultured for 18 h with a cross-linking antibody against Fc RI ␣ or a control hamster IgG. Supernatants from these cultures were then used in a modifi ed Boyden chamber assay to assess whether a functional T cell chemoattractant had been produced. Supernatants from Fc RI ␣ crosslinked cDCs induced signifi cantly more CD4 ϩ T cell migration than did IgG control supernatants, indicating that engagement of the receptor led to production of a CD4 ϩ T cell chemoattractant ( Fig. 5 B ) . To identify the chemokine receptor for this T cell chemoattractant, we added various chemokines (CCL5, CCL22, and CCL27) to the upper chamber and evaluated the eff ect on chemotaxis (Fig. S4 A, available at http://www.jem .org/cgi/content/full/jem.20070360/DC1). Only CCL27 (C-TACK) inhibited T cell migration, indicating that the CD4 ϩ T cells were moving in response to a CCR10 agonist. Only two known CCR10 agonists, CCL27 and CCL28 (MEC), have been identifi ed. Using blocking mAbs, we found that the chemotactic activity was entirely caused by CCL28 ( Fig. 5 B ) . Of relevance to this work, CCL28 has been associated with both human asthma and mouse models of asthma ( 25 -27 ) . 
DISCUSSION
In this study, we show that respiratory viral infection can lead to expression and activation of Fc RI on lung cDCs and thereby drive the development of mucous cell metaplasia even after the inciting infection is cleared. We examined lung cDCs because we previously found that the migration and maturation of this cell population was tightly regulated during respiratory viral infection ( 22 ) . Indeed, the potent eff ects of viral infection on DCs might explain why we have detected Fc RI on DCs in the mouse, whereas others have not previously found this receptor on DCs ( 28 ) .
We have also shown that expression of Fc RI in the setting of a productive viral infection requires an active type I IFN response. In fact, expression of Fc RI on cDCs quickly returns to low levels with resolution of the antiviral response, migrated compared with cells that did not migrate in response to CCL28 (Fig. S4 B) .
Because CCL28 binds to CCR10 to recruit immune cells, we determined the level of CCR10 ϩ CD4 ϩ T cells in the lungs of WT and FceRIa Ϫ / Ϫ mice before and after viral infection. We found an increase in CCR10 ϩ CD4 ϩ T cells in WT mice after viral infection ( Fig. 5 H ) . Furthermore, this increase in CCR10 ϩ CD4 ϩ T cells did not develop in FceRIa Ϫ / Ϫ mice. We also found that CCR10 ϩ CD4 ϩ lung T cells from WT mice contained increased levels of GATA-3 mRNA (typically found in Th2 cells) compared with T-bet mRNA (typically found in Th1 cells; Fig. 5 I ) . Together, these fi ndings provide further support for the proposal that activation of Fc RI ␣ on cDCs leads to preferential accumulation of Th2 cells in the lung after SeV infection.
cDC reconstitution restores CD4 ؉ T cell accumulation and mucous cell metaplasia after viral infection
To prove that Fc RI ␣ expression on cDCs was necessary for recruitment of CD4 ϩ Th2 cells to the lung and mucous cell metaplasia after viral infection, we performed adoptive cell transfer experiments with cDCs from WT or FceRIa Ϫ / Ϫ mice transferred into FceRIa Ϫ / Ϫ recipients, followed by SeV inoculation. We found that reconstitution with WT cDCs restored postviral mucous cell metaplasia in FceRIa Ϫ / Ϫ recipient mice ( Fig. 6, A and B , and Fig. S5 A, available at http://www.jem .org/cgi/content/full/jem.20070360/DC1). In contrast, transfer of FceRIa Ϫ / Ϫ cDCs were unable to restore the development of mucous cell metaplasia after viral infection. Furthermore, we found that CD4 ϩ T cells isolated at PI day 21 from lungs of FceRIa Ϫ / Ϫ mice that had received WT cDCs expressed IL-13 and GATA-3 at signifi cantly higher levels than mice that received cDCs from FceRIa Ϫ / Ϫ mice ( Fig. 6 C ) . We found no diff erence in the engraftment of WT versus FceRIa Ϫ / Ϫ cDCs, with both genotypes of cDCs persisting for at least 6 d after transfer to the recipient mice (Fig. S5 B) . Together, these results indicate that Fc RI ␣ on lung cDCs is critical for Th2 cell recruitment and mucous cell metaplasia after viral infection.
Blockade of CCL28 inhibits postviral mucous cell metaplasia
We next determined the role of CCL28 in the cascade leading to mucous cell metaplasia after viral infection. For these experiments, we treated WT mice with an anti-CCL28 -blocking mAb or control IgG2b and monitored the development of mucous cell metaplasia at PI day 21. We found a signifi cant decrease in mucous cell metaplasia after treatment with anti-CCL28 mAb compared with control IgG ( Fig. 7,  A and B , and Fig. S6 , available at http://www.jem.org/cgi/ content/full/jem.20070360/DC1). We observed no significant diff erence in the frequency of CD4 ϩ T cells in the lungs of mice treated with either anti-CCL28 mAb or control IgG2b ( Fig. 7 C ) . This fi nding suggests that CCL28 is a chemotactic factor for immune cells producing IL-13 and driving mucous cell metaplasia after viral infection, but additional chemoattractants also contribute to CD4 ϩ T cell accumulation in the lung in this setting. also uncertain. Any possible pathogenic role for IgE-dependent signals remained undefi ned, despite recognition that viral infections stimulate potent IgE responses along with neutralizing IgG antibodies ( 6 -10 ). Furthermore, increased antiviral IgE production is closely associated with subsequent wheezing in infants after respiratory viral infection ( 10 ) . Moreover, the two major pathogens linked to asthma pathogenesis, i.e., respiratory syncytial virus (a paramyxovirus-like SeV) and rhinovirus, are both known to potently induce the production of IgE in humans ( 10, 30 -33 ) . Our fi ndings provide for a novel IgE-dependent mechanism in which an antiviral response characterized by IFN production drives expression of Fc RI on lung cDCs. IgE engagement of the receptor leads to release of soluble mediators that generate an atopic response characterized by Th2 cell activation and IL-13 production. Consistent with this mechanism, others showed that passive transfer of antiviral IgE can increase the airway hyperreactivity caused by respiratory syncytial virus infection in mice, and that Fc RI was necessary for this IgE-dependent response ( 34 ) . This eff ect was assumed to be caused by mast cell activation during the viral infection. However, given the very low dissociation kinetics of Fc RI-bound IgE (K d of ‫ف‬ 10 Ϫ 9 -10 Ϫ 10 M), it is not clear that IgE during a primary viral infection would bind to mast cell Fc RI in any signifi cant quantity during the acute infection ( 35 ) . It is possible that the rapid expression of Fc RI on lung cDCs would make these cells a better target cell for binding antiviral IgE because this cell population would have a signifi cant number of unoccupied receptors. Although we did not study this issue directly, it is quite possible that virus-induced airway hyperreactivity, like mucous cell metaplasia, is a result of engagement of Fc RI on lung cDCs and not mast cells or basophils.
The actions of Fc RI found on mouse lung cDCs are distinct from the previously described role of Fc RI ␣ signaling on human DCs. In the human cells, Fc RI is thought to help target antigens to DCs ( 12 ) . Because IgE production lags behind expression of Fc RI, it appears that IgE may act as a signaling molecule for lung cDCs. Once an eff ective adaptive immune response has been generated, virus-specifi c IgE will be produced, bind to the cDCs, and be cross-linked by viral antigen. This signals cDCs to produce CCL28 and recruit eff ector Th2 cells. Because Th2 recruitment to the lung is antigen nonspecifi c, it is possible that this mechanism contributes in other ways to allow the innate immune system to infl uence the antiviral response ( 36 ) . For example, regulatory T cells express CCR10 and may be another important target of CCL28 ( 37 ) . Thus, Fc RI engagement on lung cDCs may provide mechanisms to down-regulate an ongoing Th1 response in the lung after viral infection.
These results may also bear on the increased incidence of asthma and allergic diseases that are being observed in more industrialized countries. This observation has led to the " hygiene hypothesis, " in which cleaner living conditions and decreased childhood bacterial infections are thought to drive an increase in allergic disease ( 38 ) . Our results suggest an additional mechanism that may explain the increased incidence such that expression is nearly undetectable by 21 d after viral inoculation. Previous work has shown that IgE levels regulate Fc RI expression on mast cells. In addition, the low levels of Fc RI expression found on mast cells from IgE Ϫ / Ϫ mice were attributed to IL-4 production ( 29 ) . These fi ndings now indicate that Fc RI expression on cDCs is also regulated by type I IFN. Moreover, expression on cDCs can be regulated independent of IgE levels because Fc RI levels return to baseline despite a persistent increase in IgE levels after viral infection. Thus, Fc RI on cDCs may be selectively regulated by type I IFN, at least in the mouse. Human cDCs express Fc RI at baseline, but whether these levels are increased by viral infection still needs to be determined ( 12, 13 ) .
In that regard, the consequences of IgE production and IgE -Fc RI interaction in the setting of viral infection were Mice were inoculated with SeV (Fushimi strain; American Type Culture Collection [ATCC]) or UV-inactivated SeV, as previously described, using an inoculum of 2 ϫ 10 5 pfu, and they were monitored daily for weight and activity. To track lung cDCs, mice were anesthetized and given 30 l of 5 mM CFSE intranasally, as previously described ( 2, 3, 5, 14 ) . For blockade of CCL28, mice were given 100 g of anti-CCL28 mAb or control IgG2b subcutaneously every other day from PI day 3 to 19. Mucous cell metaplasia and Muc5ac mRNA in lungs were assessed at PI day 21 as previously described ( 2, 3, 5 ) .
Lung cDC isolation. For cDC isolation, mice were killed, and intracardiac injection of PBS was used to fl ush out the pulmonary and systemic circulations. BAL was performed to remove any cells in the bronchiolar or alveolar space. Next, 1 ml of digest media was injected intratracheally. Digest medium consisted of DME supplemented with 5% fetal calf serum, penicillin/ streptokinase, 10 mM Hepes, 250 U/ml collagenase I (Worthington Biochemical), 50 U/ml DNase I (Worthington Biochemical), and 0.01% hyaluronidase (Sigma-Aldrich). The lungs were carefully dissected from the trachea, main-stem bronchi, draining lymph nodes, and surrounding tissue. The lungs were minced and incubated in digest media for 1 h at 37 ° C. During the fi nal 15 min of incubation time, EDTA was added to a fi nal concentration of 2 mM. After digestion, the cell mixture was passed through a 40-m pore cell strainer to generate single-cell suspensions, and erythrocytes were removed by hypotonic lysis. Cell viability was assessed by trypan blue exclusion. An analogous procedure was performed for removal of DCs from spleen or draining lymph nodes, as well as for isolation of T cells from C57BL6 or OT-II splenic tissue. Lung cDCs were identifi ed (and other cell populations, such as macrophages, were excluded) by fl ow cytometry, as previously described ( 22 ) .
Cell purifi cation and culture. DCs were purifi ed from lung cell suspensions using the MACS system (Miltenyi Biotec) for positive immunomagnetic selection with anti-CD11c microbeads. Using two serial purifi cations, cDC purity was Ն 95%. Cells obtained in this manner had typical cDC morphology ( Fig. 4 ) . Purifi ed cDCs were cultured with or without cross-linking antibodies in complete RPMI (Sigma-Aldrich) supplemented with 10% fetal calf serum and penicillin/streptokinase (Invitrogen) for 18 h at 37 ° C. For T cell proliferation experiments, cDCs were subjected to 200 cGyn before being loaded with 0.3 M of OVA peptide (OVA 323-339 ). CD4 ϩ T cells were purifi ed from OT-II spleens using the Miltenyi-Biotec MACS system for positive immunomagnetic selection. T cell purities were Ն 95%. Irradiated cDCs (10 4 per condition) were cultured for 4 d with 10 5 OVA-specifi c CD4 ϩ T cells with or without cross-linking antibodies. For T cell proliferation, CD4 ϩ T cells were labeled with 5 M CFSE (Invitrogen) before culture, and cell proliferation was monitored by CFSE dilution, as previously described ( 42 ) . For some experiments, lung cDCs were loaded with 10 g/ml mouse anti-OVA IgE (Serotec) for 48 h at 37 ° C, washed, and incubated with or without 3 g/ml OVA protein (Sigma-Aldrich) for 18 h at 37 ° C, followed by mRNA isolation from cell pellets. Mouse MC/9 mast cells were of asthma in the urban environment. In this setting, the increased population density, as well as other factors, may lead to increased transmission of respiratory viral infections. If viral respiratory illnesses drive Fc RI expression on lung cDCs in humans, this process could lead to an increase in lung Th2 responses in individuals with genetic susceptibility to this type of response. This mechanism is consistent with the increased incidence of asthma now being found for children living in the inner city ( 39 ) .
In summary, we have defi ned a new scheme for mucous cell metaplasia after viral infection that depends on an IF-NAR -Fc RI -CCL28 -IL-13 immune axis (Fig. S7 , available at http://www.jem.org/cgi/content/full/jem.20070360/DC1). This mechanism involves cDC expression of Fc RI and production of CCL28 in concert with T cell production of IL-13 and consequent mucous cell metaplasia. This immune axis may be more active after severe infection to help explain why more severe respiratory viral infections are associated with an increased risk of asthma. For example, the level of IgE production after SeV infection in mice appears to depend on the severity of the infection (unpublished data). The scheme also implies that exposure to even nonviral IgE and antigen during the resolution of the viral response might also lead to increased Th2 recruitment to the lung driven by additional Fc RI crosslinking and CCL28 production. This mechanism would thereby provide for an allergic-type response to nonviral antigens because Th2 cells that had migrated to the lung could be directed against nonviral antigens. In the atopic individual, these Th2 cells could lead to the development of asthma, or an exacerbation of the disease in patients with established asthma. Each of these mechanisms is distinct from previous proposals for IgE -Fc RI function in the traditional response to parasitic infection or allergen exposure. Thus, viral antigens and the consequent IFN-dependent antiviral response may also trigger an " allergic " cascade, leading to disease traits that are characteristic of asthma and other chronic airway diseases.
MATERIALS AND METHODS
Reagents and antibodies. Anti-CD16/-CD32 antibodies (clone 2.4G2; obtained from C. Pham, Washington University, St. Louis, MO) were used for fl ow cytometry, as previously described ( 40 ) . Anti -mouse CCL28 mAb or control rat IgG2b was obtained from R & D Systems. PE-or allophycocyanin-labeled antibodies against mouse CD4, CD8, CD11c, CD23, c-Kit, Fc RI ␣ (clone MAR-1), and IgE, as well as isotype control IgGs (rat and Armenian hamster), were obtained from eBioscience or BD PharMingen. SeV-specifi c CD8 ϩ T cells were monitored using tetrameric MHC/peptide reagents for the immunodominant epitope of SeV nucleoprotein (NP 324-332 ) or control OVA peptide (SIINFEKL) complexed with K(b) provided by the National Institute of Allergy and Infectious Diseases (NIAID) Tetramer Core Facility ( 41 ) . Purifi ed anti-Fc RI ␣ mAb (clone MAR-1; eBioscience) was used for immunoprecipitation, and anti-Fc RI ␤ mAb (clone JRK) obtained from J. Rivera (National Institutes of Health, Bethesda, MD) or rabbit anti-Fc RI ␥ Ab (Millipore) was used for detection of the immune complex in Western blotting. For cross-linking experiments, functional grade Armenian hamster anti -murine Fc RI ␣ or functional grade Armenian hamster IgG isotype control antibodies were obtained from eBioscience. A secondary goat anti -Armenian hamster IgG antibody purchased from Jackson ImmunoResearch Laboratories was also used.
Statistical analyses.
Unless otherwise stated, all data are presented as the mean Ϯ the SEM. Student ' s t test was used to assess statistical signifi cance between means. For nonnormally distributed data, comparison of medians was made using a Mann-Whitney U test. For comparison of ratios, Wilcoxin Signed Rank was used. In all cases, signifi cance was set at P Ͻ 0.05.
Online supplemental material. FceRIa Ϫ / Ϫ and WT mice respond similarly to SeV infection, as shown in Fig. S1 . Surface marker expression on lung cDCs from FceRIa Ϫ / Ϫ and WT mice are similar, as shown in Fig. S2 . Fig. S3 shows that IFNAR expression on lung cDCs is not necessary for Fc RI ␣ expression on lung cDCs. Fig. S4 shows the eff ect of cDC Fc RI activation on chemotaxis of CD4 ϩ T cells. The ability of WT, but not FceRIa Ϫ / Ϫ , cDC to restore postviral-induced mucous cell metaplasia in FceRIa Ϫ / Ϫ mice is demonstrated in Fig. S5 . Fig. S6 shows that postviral Muc5ac mRNA induction is inhibited with CCL28 blockade. As shown in Fig. S7 , our data support a scheme whereby an IFN -Fc RI -CCL28 -IL-13 signaling pathway regulates mucous cell metaplasia after viral infection. The online version of this article is available at http://www.jem .org/cgi/content/full/jem.20070360/DC1.
